0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pathology Microtome Blades Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-10B16957
Home | Market Reports | Science| Biological Sciences
Global Pathology Microtome Blades Market Research Report 2024
BUY CHAPTERS

Global Pathology Microtome Blades Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-10B16957
Report
November 2025
Pages:175
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pathology Microtome Blades Market Size

The global Pathology Microtome Blades market is projected to grow from US$ 53 million in 2024 to US$ 75.9 million by 2031, at a CAGR of 5.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Pathology Microtome Blades Market

Pathology Microtome Blades Market

Pathology microtome blades are specialized cutting tools used in histology and pathology laboratories to precisely section tissue specimens for microscopic examination. These blades are designed to produce thin, uniform sections of tissue samples, allowing pathologists to study cellular structures and diagnose diseases accurately.
The Pathology Microtome Blades market is driven by the increasing demand for precise and high-quality tissue sectioning in pathology and histology labs. With the rising prevalence of chronic diseases, particularly cancer, there is a growing need for accurate diagnostic tools, which in turn boosts the demand for microtome blades. These blades are essential for producing thin, uniform tissue sections that are critical for microscopic analysis and diagnosis. Additionally, advancements in blade materials, such as tungsten carbide and diamond-coated blades, have improved durability, precision, and cutting efficiency, making them highly sought after in clinical and research settings. The growth of personalized medicine and the expansion of laboratory infrastructure in emerging markets further fuel market expansion.
However, the Pathology Microtome Blades market faces challenges, including the high cost of premium blades, which may limit adoption in cost-sensitive regions and smaller laboratories. Moreover, the lack of skilled technicians capable of using microtomes effectively can lead to suboptimal results and reduced operational efficiency, particularly in under-resourced healthcare systems. Additionally, the increasing automation in tissue processing and digital pathology may reduce the reliance on traditional microtome-based sectioning, posing a potential long-term challenge for the market. Addressing these issues will require cost-effective solutions, comprehensive training programs, and adaptability to evolving laboratory technologies.

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Pathology Microtome Blades market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Pathology Microtome Blades Market Report

Report Metric Details
Report Name Pathology Microtome Blades Market
Accounted market size in 2024 US$ 53 million
Forecasted market size in 2031 US$ 75.9 million
CAGR 5.2%
Base Year 2024
Forecasted years 2025 - 2031
Segment by Type
  • Low Profile Blades
  • High Profile Blades
  • Others
Segment by Application
  • Research
  • Clinical
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Leica Biosystems, Epredia, PFM Medical, Sakura Finetek, CL Sturkey, AccuTec Blades, Diapath, Trajan, Crescent Blades, General Data, StatLab, Avantik, Histoline, Kaltek Srl, SLEE medical, Citotest Scientific
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Pathology Microtome Blades study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

How fast is Pathology Microtome Blades Market growing?

Ans: The Pathology Microtome Blades Market witnessing a CAGR of 5.2% during the forecast period 2025-2031.

What is the Pathology Microtome Blades Market size in 2031?

Ans: The Pathology Microtome Blades Market size in 2031 will be US$ 75.9 million.

Who are the main players in the Pathology Microtome Blades Market report?

Ans: The main players in the Pathology Microtome Blades Market are Leica Biosystems, Epredia, PFM Medical, Sakura Finetek, CL Sturkey, AccuTec Blades, Diapath, Trajan, Crescent Blades, General Data, StatLab, Avantik, Histoline, Kaltek Srl, SLEE medical, Citotest Scientific

What are the Application segmentation covered in the Pathology Microtome Blades Market report?

Ans: The Applications covered in the Pathology Microtome Blades Market report are Research, Clinical, Others

What are the Type segmentation covered in the Pathology Microtome Blades Market report?

Ans: The Types covered in the Pathology Microtome Blades Market report are Low Profile Blades, High Profile Blades, Others

1 Study Coverage
1.1 Introduction to Pathology Microtome Blades: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Pathology Microtome Blades Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Low Profile Blades
1.2.3 High Profile Blades
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Pathology Microtome Blades Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Research
1.3.3 Clinical
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pathology Microtome Blades Revenue Estimates and Forecasts 2020-2031
2.2 Global Pathology Microtome Blades Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Pathology Microtome Blades Sales Estimates and Forecasts 2020-2031
2.4 Global Pathology Microtome Blades Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Pathology Microtome Blades Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Pathology Microtome Blades Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Low Profile Blades Market Size by Manufacturers
3.5.2 High Profile Blades Market Size by Manufacturers
3.5.3 Others Market Size by Manufacturers
3.6 Global Pathology Microtome Blades Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Pathology Microtome Blades Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Pathology Microtome Blades Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Pathology Microtome Blades Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Pathology Microtome Blades Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Pathology Microtome Blades Sales and Revenue by Type (2020-2031)
6.4 North America Pathology Microtome Blades Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Pathology Microtome Blades Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Pathology Microtome Blades Sales and Revenue by Type (2020-2031)
7.4 Europe Pathology Microtome Blades Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Pathology Microtome Blades Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Pathology Microtome Blades Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Pathology Microtome Blades Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Pathology Microtome Blades Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Pathology Microtome Blades Sales and Revenue by Type (2020-2031)
9.4 Central and South America Pathology Microtome Blades Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Pathology Microtome Blades Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Pathology Microtome Blades Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Pathology Microtome Blades Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Pathology Microtome Blades Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Leica Biosystems
11.1.1 Leica Biosystems Corporation Information
11.1.2 Leica Biosystems Business Overview
11.1.3 Leica Biosystems Pathology Microtome Blades Product Models, Descriptions and Specifications
11.1.4 Leica Biosystems Pathology Microtome Blades Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Leica Biosystems Pathology Microtome Blades Sales by Product in 2024
11.1.6 Leica Biosystems Pathology Microtome Blades Sales by Application in 2024
11.1.7 Leica Biosystems Pathology Microtome Blades Sales by Geographic Area in 2024
11.1.8 Leica Biosystems Pathology Microtome Blades SWOT Analysis
11.1.9 Leica Biosystems Recent Developments
11.2 Epredia
11.2.1 Epredia Corporation Information
11.2.2 Epredia Business Overview
11.2.3 Epredia Pathology Microtome Blades Product Models, Descriptions and Specifications
11.2.4 Epredia Pathology Microtome Blades Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Epredia Pathology Microtome Blades Sales by Product in 2024
11.2.6 Epredia Pathology Microtome Blades Sales by Application in 2024
11.2.7 Epredia Pathology Microtome Blades Sales by Geographic Area in 2024
11.2.8 Epredia Pathology Microtome Blades SWOT Analysis
11.2.9 Epredia Recent Developments
11.3 PFM Medical
11.3.1 PFM Medical Corporation Information
11.3.2 PFM Medical Business Overview
11.3.3 PFM Medical Pathology Microtome Blades Product Models, Descriptions and Specifications
11.3.4 PFM Medical Pathology Microtome Blades Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 PFM Medical Pathology Microtome Blades Sales by Product in 2024
11.3.6 PFM Medical Pathology Microtome Blades Sales by Application in 2024
11.3.7 PFM Medical Pathology Microtome Blades Sales by Geographic Area in 2024
11.3.8 PFM Medical Pathology Microtome Blades SWOT Analysis
11.3.9 PFM Medical Recent Developments
11.4 Sakura Finetek
11.4.1 Sakura Finetek Corporation Information
11.4.2 Sakura Finetek Business Overview
11.4.3 Sakura Finetek Pathology Microtome Blades Product Models, Descriptions and Specifications
11.4.4 Sakura Finetek Pathology Microtome Blades Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Sakura Finetek Pathology Microtome Blades Sales by Product in 2024
11.4.6 Sakura Finetek Pathology Microtome Blades Sales by Application in 2024
11.4.7 Sakura Finetek Pathology Microtome Blades Sales by Geographic Area in 2024
11.4.8 Sakura Finetek Pathology Microtome Blades SWOT Analysis
11.4.9 Sakura Finetek Recent Developments
11.5 CL Sturkey
11.5.1 CL Sturkey Corporation Information
11.5.2 CL Sturkey Business Overview
11.5.3 CL Sturkey Pathology Microtome Blades Product Models, Descriptions and Specifications
11.5.4 CL Sturkey Pathology Microtome Blades Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 CL Sturkey Pathology Microtome Blades Sales by Product in 2024
11.5.6 CL Sturkey Pathology Microtome Blades Sales by Application in 2024
11.5.7 CL Sturkey Pathology Microtome Blades Sales by Geographic Area in 2024
11.5.8 CL Sturkey Pathology Microtome Blades SWOT Analysis
11.5.9 CL Sturkey Recent Developments
11.6 AccuTec Blades
11.6.1 AccuTec Blades Corporation Information
11.6.2 AccuTec Blades Business Overview
11.6.3 AccuTec Blades Pathology Microtome Blades Product Models, Descriptions and Specifications
11.6.4 AccuTec Blades Pathology Microtome Blades Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 AccuTec Blades Recent Developments
11.7 Diapath
11.7.1 Diapath Corporation Information
11.7.2 Diapath Business Overview
11.7.3 Diapath Pathology Microtome Blades Product Models, Descriptions and Specifications
11.7.4 Diapath Pathology Microtome Blades Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Diapath Recent Developments
11.8 Trajan
11.8.1 Trajan Corporation Information
11.8.2 Trajan Business Overview
11.8.3 Trajan Pathology Microtome Blades Product Models, Descriptions and Specifications
11.8.4 Trajan Pathology Microtome Blades Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Trajan Recent Developments
11.9 Crescent Blades
11.9.1 Crescent Blades Corporation Information
11.9.2 Crescent Blades Business Overview
11.9.3 Crescent Blades Pathology Microtome Blades Product Models, Descriptions and Specifications
11.9.4 Crescent Blades Pathology Microtome Blades Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Crescent Blades Recent Developments
11.10 General Data
11.10.1 General Data Corporation Information
11.10.2 General Data Business Overview
11.10.3 General Data Pathology Microtome Blades Product Models, Descriptions and Specifications
11.10.4 General Data Pathology Microtome Blades Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 General Data Recent Developments
11.11 StatLab
11.11.1 StatLab Corporation Information
11.11.2 StatLab Business Overview
11.11.3 StatLab Pathology Microtome Blades Product Models, Descriptions and Specifications
11.11.4 StatLab Pathology Microtome Blades Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 StatLab Recent Developments
11.12 Avantik
11.12.1 Avantik Corporation Information
11.12.2 Avantik Business Overview
11.12.3 Avantik Pathology Microtome Blades Product Models, Descriptions and Specifications
11.12.4 Avantik Pathology Microtome Blades Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Avantik Recent Developments
11.13 Histoline
11.13.1 Histoline Corporation Information
11.13.2 Histoline Business Overview
11.13.3 Histoline Pathology Microtome Blades Product Models, Descriptions and Specifications
11.13.4 Histoline Pathology Microtome Blades Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Histoline Recent Developments
11.14 Kaltek Srl
11.14.1 Kaltek Srl Corporation Information
11.14.2 Kaltek Srl Business Overview
11.14.3 Kaltek Srl Pathology Microtome Blades Product Models, Descriptions and Specifications
11.14.4 Kaltek Srl Pathology Microtome Blades Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Kaltek Srl Recent Developments
11.15 SLEE medical
11.15.1 SLEE medical Corporation Information
11.15.2 SLEE medical Business Overview
11.15.3 SLEE medical Pathology Microtome Blades Product Models, Descriptions and Specifications
11.15.4 SLEE medical Pathology Microtome Blades Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 SLEE medical Recent Developments
11.16 Citotest Scientific
11.16.1 Citotest Scientific Corporation Information
11.16.2 Citotest Scientific Business Overview
11.16.3 Citotest Scientific Pathology Microtome Blades Product Models, Descriptions and Specifications
11.16.4 Citotest Scientific Pathology Microtome Blades Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 Citotest Scientific Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Pathology Microtome Blades Industry Chain
12.2 Pathology Microtome Blades Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Pathology Microtome Blades Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Pathology Microtome Blades Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Pathology Microtome Blades Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Pathology Microtome Blades Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Pathology Microtome Blades Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Pathology Microtome Blades Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Pathology Microtome Blades Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Pathology Microtome Blades Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Pathology Microtome Blades Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Pathology Microtome Blades Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Pathology Microtome Blades Sales by Region (2020-2025) & (K Units)
 Table 8. Global Pathology Microtome Blades Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Pathology Microtome Blades Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Pathology Microtome Blades Sales Share by Manufacturers (2020-2025)
 Table 12. Global Pathology Microtome Blades Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Pathology Microtome Blades Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Pathology Microtome Blades by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pathology Microtome Blades as of 2024)
 Table 16. Global Pathology Microtome Blades Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Pathology Microtome Blades Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Pathology Microtome Blades Manufacturing Base and Headquarters
 Table 19. Global Pathology Microtome Blades Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Pathology Microtome Blades Sales by Type (2020-2025) & (K Units)
 Table 23. Global Pathology Microtome Blades Sales by Type (2026-2031) & (K Units)
 Table 24. Global Pathology Microtome Blades Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Pathology Microtome Blades Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Pathology Microtome Blades ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Pathology Microtome Blades Sales by Application (2020-2025) & (K Units)
 Table 29. Global Pathology Microtome Blades Sales by Application (2026-2031) & (K Units)
 Table 30. Pathology Microtome Blades High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Pathology Microtome Blades Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Pathology Microtome Blades Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Pathology Microtome Blades ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Pathology Microtome Blades Growth Accelerators and Market Barriers
 Table 37. North America Pathology Microtome Blades Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Pathology Microtome Blades Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Pathology Microtome Blades Growth Accelerators and Market Barriers
 Table 40. Europe Pathology Microtome Blades Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Pathology Microtome Blades Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Pathology Microtome Blades Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Pathology Microtome Blades Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Pathology Microtome Blades Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Pathology Microtome Blades Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Pathology Microtome Blades Investment Opportunities and Key Challenges
 Table 47. Central and South America Pathology Microtome Blades Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Pathology Microtome Blades Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Pathology Microtome Blades Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Leica Biosystems Corporation Information
 Table 51. Leica Biosystems Description and Major Businesses
 Table 52. Leica Biosystems Product Models, Descriptions and Specifications
 Table 53. Leica Biosystems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Leica Biosystems Sales Value Proportion by Product in 2024
 Table 55. Leica Biosystems Sales Value Proportion by Application in 2024
 Table 56. Leica Biosystems Sales Value Proportion by Geographic Area in 2024
 Table 57. Leica Biosystems Pathology Microtome Blades SWOT Analysis
 Table 58. Leica Biosystems Recent Developments
 Table 59. Epredia Corporation Information
 Table 60. Epredia Description and Major Businesses
 Table 61. Epredia Product Models, Descriptions and Specifications
 Table 62. Epredia Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Epredia Sales Value Proportion by Product in 2024
 Table 64. Epredia Sales Value Proportion by Application in 2024
 Table 65. Epredia Sales Value Proportion by Geographic Area in 2024
 Table 66. Epredia Pathology Microtome Blades SWOT Analysis
 Table 67. Epredia Recent Developments
 Table 68. PFM Medical Corporation Information
 Table 69. PFM Medical Description and Major Businesses
 Table 70. PFM Medical Product Models, Descriptions and Specifications
 Table 71. PFM Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. PFM Medical Sales Value Proportion by Product in 2024
 Table 73. PFM Medical Sales Value Proportion by Application in 2024
 Table 74. PFM Medical Sales Value Proportion by Geographic Area in 2024
 Table 75. PFM Medical Pathology Microtome Blades SWOT Analysis
 Table 76. PFM Medical Recent Developments
 Table 77. Sakura Finetek Corporation Information
 Table 78. Sakura Finetek Description and Major Businesses
 Table 79. Sakura Finetek Product Models, Descriptions and Specifications
 Table 80. Sakura Finetek Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Sakura Finetek Sales Value Proportion by Product in 2024
 Table 82. Sakura Finetek Sales Value Proportion by Application in 2024
 Table 83. Sakura Finetek Sales Value Proportion by Geographic Area in 2024
 Table 84. Sakura Finetek Pathology Microtome Blades SWOT Analysis
 Table 85. Sakura Finetek Recent Developments
 Table 86. CL Sturkey Corporation Information
 Table 87. CL Sturkey Description and Major Businesses
 Table 88. CL Sturkey Product Models, Descriptions and Specifications
 Table 89. CL Sturkey Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. CL Sturkey Sales Value Proportion by Product in 2024
 Table 91. CL Sturkey Sales Value Proportion by Application in 2024
 Table 92. CL Sturkey Sales Value Proportion by Geographic Area in 2024
 Table 93. CL Sturkey Pathology Microtome Blades SWOT Analysis
 Table 94. CL Sturkey Recent Developments
 Table 95. AccuTec Blades Corporation Information
 Table 96. AccuTec Blades Description and Major Businesses
 Table 97. AccuTec Blades Product Models, Descriptions and Specifications
 Table 98. AccuTec Blades Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. AccuTec Blades Recent Developments
 Table 100. Diapath Corporation Information
 Table 101. Diapath Description and Major Businesses
 Table 102. Diapath Product Models, Descriptions and Specifications
 Table 103. Diapath Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Diapath Recent Developments
 Table 105. Trajan Corporation Information
 Table 106. Trajan Description and Major Businesses
 Table 107. Trajan Product Models, Descriptions and Specifications
 Table 108. Trajan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. Trajan Recent Developments
 Table 110. Crescent Blades Corporation Information
 Table 111. Crescent Blades Description and Major Businesses
 Table 112. Crescent Blades Product Models, Descriptions and Specifications
 Table 113. Crescent Blades Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. Crescent Blades Recent Developments
 Table 115. General Data Corporation Information
 Table 116. General Data Description and Major Businesses
 Table 117. General Data Product Models, Descriptions and Specifications
 Table 118. General Data Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. General Data Recent Developments
 Table 120. StatLab Corporation Information
 Table 121. StatLab Description and Major Businesses
 Table 122. StatLab Product Models, Descriptions and Specifications
 Table 123. StatLab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 124. StatLab Recent Developments
 Table 125. Avantik Corporation Information
 Table 126. Avantik Description and Major Businesses
 Table 127. Avantik Product Models, Descriptions and Specifications
 Table 128. Avantik Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 129. Avantik Recent Developments
 Table 130. Histoline Corporation Information
 Table 131. Histoline Description and Major Businesses
 Table 132. Histoline Product Models, Descriptions and Specifications
 Table 133. Histoline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 134. Histoline Recent Developments
 Table 135. Kaltek Srl Corporation Information
 Table 136. Kaltek Srl Description and Major Businesses
 Table 137. Kaltek Srl Product Models, Descriptions and Specifications
 Table 138. Kaltek Srl Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 139. Kaltek Srl Recent Developments
 Table 140. SLEE medical Corporation Information
 Table 141. SLEE medical Description and Major Businesses
 Table 142. SLEE medical Product Models, Descriptions and Specifications
 Table 143. SLEE medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 144. SLEE medical Recent Developments
 Table 145. Citotest Scientific Corporation Information
 Table 146. Citotest Scientific Description and Major Businesses
 Table 147. Citotest Scientific Product Models, Descriptions and Specifications
 Table 148. Citotest Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 149. Citotest Scientific Recent Developments
 Table 150. Key Raw Materials Distribution
 Table 151. Raw Materials Key Suppliers
 Table 152. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 153. Milestones in Production Technology Evolution
 Table 154. Distributors List
 Table 155. Market Trends and Market Evolution
 Table 156. Market Drivers and Opportunities
 Table 157. Market Challenges, Risks, and Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources


List of Figures
 Figure 1. Pathology Microtome Blades Product Picture
 Figure 2. Global Pathology Microtome Blades Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Low Profile Blades Product Picture
 Figure 4. High Profile Blades Product Picture
 Figure 5. Others Product Picture
 Figure 6. Global Pathology Microtome Blades Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Research
 Figure 8. Clinical
 Figure 9. Others
 Figure 10. Pathology Microtome Blades Report Years Considered
 Figure 11. Global Pathology Microtome Blades Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Pathology Microtome Blades Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Pathology Microtome Blades Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Pathology Microtome Blades Revenue Market Share by Region (2020-2031)
 Figure 15. Global Pathology Microtome Blades Sales (2020-2031) & (K Units)
 Figure 16. Global Pathology Microtome Blades Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 17. Global Pathology Microtome Blades Sales Market Share by Region (2020-2031)
 Figure 18. Top 5 and Top 10 Manufacturers Pathology Microtome Blades Sales Volume Market Share in 2024
 Figure 19. Global Pathology Microtome Blades Revenue Market Share Ranking (2024)
 Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 21. Low Profile Blades Revenue Market Share by Manufacturer in 2024
 Figure 22. High Profile Blades Revenue Market Share by Manufacturer in 2024
 Figure 23. Others Revenue Market Share by Manufacturer in 2024
 Figure 24. Global Pathology Microtome Blades Sales Market Share by Type (2020-2031)
 Figure 25. Global Pathology Microtome Blades Revenue Market Share by Type (2020-2031)
 Figure 26. Global Pathology Microtome Blades Sales Market Share by Application (2020-2031)
 Figure 27. Global Pathology Microtome Blades Revenue Market Share by Application (2020-2031)
 Figure 28. North America Pathology Microtome Blades Sales YoY (2020-2031) & (K Units)
 Figure 29. North America Pathology Microtome Blades Revenue YoY (2020-2031) & (US$ Million)
 Figure 30. North America Top 5 Manufacturers Pathology Microtome Blades Sales Revenue (US$ Million) in 2024
 Figure 31. North America Pathology Microtome Blades Sales Volume (K Units) by Type (2020- 2031)
 Figure 32. North America Pathology Microtome Blades Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 33. North America Pathology Microtome Blades Sales Volume (K Units) by Application (2020-2031)
 Figure 34. North America Pathology Microtome Blades Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 35. US Pathology Microtome Blades Revenue (2020-2031) & (US$ Million)
 Figure 36. Canada Pathology Microtome Blades Revenue (2020-2031) & (US$ Million)
 Figure 37. Mexico Pathology Microtome Blades Revenue (2020-2031) & (US$ Million)
 Figure 38. Europe Pathology Microtome Blades Sales YoY (2020-2031) & (K Units)
 Figure 39. Europe Pathology Microtome Blades Revenue YoY (2020-2031) & (US$ Million)
 Figure 40. Europe Top 5 Manufacturers Pathology Microtome Blades Sales Revenue (US$ Million) in 2024
 Figure 41. Europe Pathology Microtome Blades Sales Volume (K Units) by Type (2020-2031)
 Figure 42. Europe Pathology Microtome Blades Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 43. Europe Pathology Microtome Blades Sales Volume (K Units) by Application (2020-2031)
 Figure 44. Europe Pathology Microtome Blades Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 45. Germany Pathology Microtome Blades Revenue (2020-2031) & (US$ Million)
 Figure 46. France Pathology Microtome Blades Revenue (2020-2031) & (US$ Million)
 Figure 47. U.K. Pathology Microtome Blades Revenue (2020-2031) & (US$ Million)
 Figure 48. Italy Pathology Microtome Blades Revenue (2020-2031) & (US$ Million)
 Figure 49. Russia Pathology Microtome Blades Revenue (2020-2031) & (US$ Million)
 Figure 50. Asia-Pacific Pathology Microtome Blades Sales YoY (2020-2031) & (K Units)
 Figure 51. Asia-Pacific Pathology Microtome Blades Revenue YoY (2020-2031) & (US$ Million)
 Figure 52. Asia-Pacific Top 8 Manufacturers Pathology Microtome Blades Sales Revenue (US$ Million) in 2024
 Figure 53. Asia-Pacific Pathology Microtome Blades Sales Volume (K Units) by Type (2020- 2031)
 Figure 54. Asia-Pacific Pathology Microtome Blades Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 55. Asia-Pacific Pathology Microtome Blades Sales Volume (K Units) by Application (2020-2031)
 Figure 56. Asia-Pacific Pathology Microtome Blades Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 57. Indonesia Pathology Microtome Blades Revenue (2020-2031) & (US$ Million)
 Figure 58. Japan Pathology Microtome Blades Revenue (2020-2031) & (US$ Million)
 Figure 59. South Korea Pathology Microtome Blades Revenue (2020-2031) & (US$ Million)
 Figure 60. China Taiwan Pathology Microtome Blades Revenue (2020-2031) & (US$ Million)
 Figure 61. India Pathology Microtome Blades Revenue (2020-2031) & (US$ Million)
 Figure 62. Central and South America Pathology Microtome Blades Sales YoY (2020-2031) & (K Units)
 Figure 63. Central and South America Pathology Microtome Blades Revenue YoY (2020-2031) & (US$ Million)
 Figure 64. Central and South America Top 5 Manufacturers Pathology Microtome Blades Sales Revenue (US$ Million) in 2024
 Figure 65. Central and South America Pathology Microtome Blades Sales Volume (K Units) by Type (2021-2031)
 Figure 66. Central and South America Pathology Microtome Blades Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 67. Central and South America Pathology Microtome Blades Sales Volume (K Units) by Application (2020-2031)
 Figure 68. Central and South America Pathology Microtome Blades Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 69. Brazil Pathology Microtome Blades Revenue (2020-2025) & (US$ Million)
 Figure 70. Argentina Pathology Microtome Blades Revenue (2020-2025) & (US$ Million)
 Figure 71. Middle East, and Africa Pathology Microtome Blades Sales YoY (2020-2031) & (K Units)
 Figure 72. Middle East and Africa Pathology Microtome Blades Revenue YoY (2020-2031) & (US$ Million)
 Figure 73. Middle East and Africa Top 5 Manufacturers Pathology Microtome Blades Sales Revenue (US$ Million) in 2024
 Figure 74. Middle East and Africa Pathology Microtome Blades Sales Volume (K Units) by Type (2021-2031)
 Figure 75. South America Pathology Microtome Blades Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 76. Middle East and Africa Pathology Microtome Blades Sales Volume (K Units) by Application (2020-2031)
 Figure 77. Middle East and Africa Pathology Microtome Blades Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 78. GCC Countries Pathology Microtome Blades Revenue (2020-2025) & (US$ Million)
 Figure 79. Turkey Pathology Microtome Blades Revenue (2020-2025) & (US$ Million)
 Figure 80. Egypt Pathology Microtome Blades Revenue (2020-2025) & (US$ Million)
 Figure 81. South Africa Pathology Microtome Blades Revenue (2020-2025) & (US$ Million)
 Figure 82. Pathology Microtome Blades Industry Chain Mapping
 Figure 83. Regional Pathology Microtome Blades Manufacturing Base Distribution (%)
 Figure 84. Global Pathology Microtome Blades Production Market Share by Region (2020-2031)
 Figure 85. Pathology Microtome Blades Production Process
 Figure 86. Regional Pathology Microtome Blades Production Cost Structure
 Figure 87. Channels of Distribution (Direct Vs Distribution)
 Figure 88. Bottom-up and Top-down Approaches for This Report
 Figure 89. Data Triangulation
 Figure 90. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

RELATED REPORTS

Global Cell-free DNA Testing Service Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-18B20127
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global cfDNA Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-36H20013
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Strong Cation Exchange Agarose Gel Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7C20305
Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Deoxyadenosine Triphosphate Solution Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13N20234
Thu Nov 27 00:00:00 UTC 2025

Add to Cart